CHINA SETS YUAN CENTRAL PARITY AT 7.1291 TUES VS 7.1265

MNI BRIEF: Williams Is Confident Fed Getting Inflation Back To 2%

MNI China Daily Summary: Monday, July 1

MNI BRIEF: PBOC To Borrow CGBs In Response To Market Situation

MNI BRIEF: Caixin June Manufacturing PMI Hits Three-year High

June CPI Below Market Expectations, Headline Y/Y At 2.4%

MNI: UK JUN BRC SHOP PRICES -0.2% M/M, +0.2% Y/Y

Multivariate Core Trend Inflation Falls To Post-2020 Low

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

EMA: Possible Link To Clot From J&J Jab, But Benefit-Risk Still Positive

EUROPE

EMA has published its findings following investigation into the Janssen/J&J COVID-19 vaccination stating that the organisation has found a possible link between the vaccination and a very rare form of blood clot with low platelet counts.

  • Importantly says the overall benefit-risk of the vaccine is still positive in favour of taking the inoculation over not doing so.
  • In a similar outcome to the investigation of the Oxford/AstraZeneca vaccine, the EMA says all cases occurred in people under the age of 60 within three weeks of receiving the injection, with the majority of cases in women.
  • Link to full statement: https://www.ema.europa.eu/en/news/covid-19-vaccine...
  • EMA to hold a presser on the subject at 1700CET (1100ET, 1600BST ): https://t.co/H4xlcn1Cok
Homepagemarkets-real-timePolitical RiskPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.